title: Blockade of both alpha1A- and alpha1B-adrenergic receptor subtype signaling is required to inhibit neointimal formation in the mouse femoral artery.
abstract: Attenuation of early restenosis after percutaneous coronary intervention (PCI) is important for the successful treatment of coronary artery disease. Some clinical studies have shown that hypertension is a risk factor for early restenosis after PCI. These findings suggest that alpha(1)-adrenergic receptors (alpha(1)-ARs) may facilitate restenosis after PCI because of alpha(1)-AR's remarkable contribution to the onset of hypertension. In this study, we examined the neointimal formation after vascular injury in the femoral artery of alpha(1A)-knockout (alpha(1A)-KO), alpha(1B)-KO, alpha(1D)-KO, alpha(1A)-/alpha(1B)-AR double-KO (alpha(1AB)-KO), and wild-type mice to investigate the functional role of each alpha(1)-AR subtype in neointimal formation, which is known to promote restenosis. Neointimal formation 4 wk after wire injury was significantly (P < 0.05) smaller in alpha(1AB)-KO mice than in any other group of mice, while blood pressures were not altered in any of the groups of mice after wire injury compared with those before it. These results suggest that lack of both alpha(1A)- and alpha(1B)-ARs could be necessary to inhibit neointimal formation in the mouse femoral artery.
authors: Department of Pharmacology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.
authors: Chihiro
authors: C
authors: Hosoda
authors: Masami
authors: M
authors: Hiroyama
authors: Atsushi
authors: A
authors: Sanbe
authors: Jun-ichi
authors: J
authors: Birumachi
authors: Tadaichi
authors: T
authors: Kitamura
authors: Susanna
authors: S
authors: Cotecchia
authors: Paul C
authors: PC
authors: Simpson
authors: Gozoh
authors: G
authors: Tsujimoto
authors: Akito
authors: A
authors: Tanoue
mesh_terms: D058668:Adrenergic alpha-1 Receptor Antagonists; D000818:Animals; D005263:Femoral Artery / Q000293:injuries / Q000378:metabolism* / Q000473:pathology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D018340:Receptors, Adrenergic, alpha-1 / Q000378:metabolism*; D015398:Signal Transduction; D017539:Tunica Intima / Q000378:metabolism* / Q000473:pathology*
chemical_list: C547714:Adra1a protein, mouse; C547717:Adra1b protein, mouse; D058668:Adrenergic alpha-1 Receptor Antagonists; D018340:Receptors, Adrenergic, alpha-1